Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
315 E Broadway
Fl 4
Louisville, KY 40202Phone+1 502-629-2500Fax+1 502-629-2055
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1998 - 2000
- Duke University HospitalResidency, Internal Medicine, 1995 - 1996
- Duke University HospitalResidency, Internal Medicine, 1992 - 1993
- Nishtar Medical CollegeClass of 1984
Certifications & Licensure
- IN State Medical License 2000 - 2025
- KY State Medical License 2008 - 2025
- AZ State Medical License 2011 - 2016
- NC State Medical License 1999 - 2004
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 74 citationsA Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's LymphomaKhuda D. Khan, Christos Emmanouilides, Don M. Benson, Deborah Hurst, Pablo Garcia
Clinical Cancer Research. 2006-12-01 - 222 citationsTransactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cellsFrancine L. Roudabush, Kristen L. Pierce, Stuart Maudsley, Khuda Dad Khan, Louis M. Luttrell
The Journal of Biological Chemistry. 2000-07-21 - 163 citationsβ-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC ROLE OF β-ARRESTIN1-DEPENDENT TARGETING OF c-SRC IN RECEPTOR ENDOCYTOSISWilliam E. Miller, Stuart Maudsley, Seungkirl Ahn, Khuda Dad Khan, Louis M. Luttrell
The Journal of Biological Chemistry. 2000-04-14
Press Mentions
- ESPN's Bob Valvano, Jim Valvano's Brother, Announces He Has CancerApril 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: